AstraZeneca’s (AZN) “Buy” Rating Reiterated at Berenberg Bank
Berenberg Bank reaffirmed their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. Berenberg Bank currently has a GBX 140 ($1.81) price objective on the biopharmaceutical company’s stock. A number of other brokerages also recently commented on AZN. JPMorgan Chase & […]
Berenberg Bank reaffirmed their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. Berenberg Bank currently has a GBX 140 ($1.81) price objective on the biopharmaceutical company’s stock. A number of other brokerages also recently commented on AZN. JPMorgan Chase & […]
